Al's Comment:

 The results are outstanding. Over 200% increase in the 5 year survival rate for newly diagnosed Glioblastomas as well as in the 30 month survival for recurrent Glioblastoma. There has been some unfair criticism of the trial on the internet -but watch the video and get the details directly from the source!   The same criticism happened after every major trial for brain tumors this century.  I used to think there were just people who could not grasp the details and we were just not explaining things right, but it turned out that it was just a few people trying to manipulate the stock market and has nothing to do with the actual science.  When you see anything about this or any trial - consider the source. If it is a financial blog, just ignore it!


Posted on: 05/13/2022

 DCVax-L Phase 3 Clinical Trial Results - Video Posted!

In our last issue of this Brain Tumor News Blast, I announced that the results of the trial were presented on our website as the slides used in the presentation.  I have now posted the video of the presentation, along with the questions and answers at the end!   To see the impressive results, go to virtualtrials.org/dcvax

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click HERE to read it!